<?xml version="1.0" encoding="UTF-8"?>
<payload xmlns:ser="http://services.ctep.nci.nih.gov/" xmlns:soapenv="http://schemas.xmlsoap.org/soap/envelope/">
    <system>adeers</system>
    <response>
        <entity>study</entity>
        <operation name="getStudyDetails">
            <data>
                <StudyDetails xmlns:S="http://schemas.xmlsoap.org/soap/envelope/"
                              xmlns:ns2="http://services.ctep.nci.nih.gov/">
                    <ctcVersion>4.0</ctcVersion>
                    <currentStatus>Complete</currentStatus>
                    <currentStatusDate>1997-05-19</currentStatusDate>
                    <monitoringMethod>Other</monitoringMethod>
                    <nciDocumentNum>INT-0018</nciDocumentNum>
                    <participantionType>Multi-Center</participantionType>
                    <phase>III</phase>
                    <primaryStudyType>Treatment</primaryStudyType>
                    <sponsorOrganization>CTEP</sponsorOrganization>
                    <studyAgents>
                        <studyAgent lead="No" updatedDate="02-11-2003 17:58:22" createdDate="07-17-1999 16:08:30">
                            <agent>
                                <nscNumber>26271</nscNumber>
                                <agentName>Cyclophosphamide</agentName>
                                <agentStatus>Active</agentStatus>
                                <inds/>
                            </agent>
                            <commercialInvestigational>Commercial</commercialInvestigational>
                        </studyAgent>
                        <studyAgent lead="No" updatedDate="02-11-2003 17:58:22" createdDate="07-17-1999 16:08:30">
                            <agent>
                                <nscNumber>45388</nscNumber>
                                <agentName>Dacarbazine</agentName>
                                <agentStatus>Active</agentStatus>
                                <inds/>
                            </agent>
                            <commercialInvestigational>Commercial</commercialInvestigational>
                        </studyAgent>
                        <studyAgent lead="No" updatedDate="02-11-2003 17:58:22" createdDate="07-17-1999 16:08:30">
                            <agent>
                                <nscNumber>123127</nscNumber>
                                <agentName>Doxorubicin hydrochloride</agentName>
                                <agentStatus>Active</agentStatus>
                                <inds/>
                            </agent>
                            <commercialInvestigational>Commercial</commercialInvestigational>
                        </studyAgent>
                    </studyAgents>
                    <studyDevices/>
                    <studyDiseases>
                        <studyDisease lead="Yes" updatedDate="12-29-2004 17:36:17" createdDate="07-17-1999 15:53:36">
                            <reportingMedDRA>10027410</reportingMedDRA>
                        </studyDisease>
                    </studyDiseases>
                    <studyOrganizations>
                        <studyOrganization role="Document to Lead Organization" updatedDate="08-29-2004 15:28:42"
                                           createdDate="12-18-1998 18:10:23">
                            <organization>
                                <ctepId>MI020</ctepId>
                                <organizationName>Wayne State University</organizationName>
                                <organizationType>CCR</organizationType>
                            </organization>
                            <status>Active</status>
                            <statusDate>01-01-1980 00:00:00</statusDate>
                            <principalInvestigator/>
                        </studyOrganization>
                        <studyOrganization role="Document to Participant Organization" updatedDate="01-04-2001 17:16:17"
                                           createdDate="12-29-1998 15:33:31">
                            <organization>
                                <ctepId>ECOG</ctepId>
                                <organizationName>Eastern Cooperative Oncology Group</organizationName>
                                <organizationType>CGP</organizationType>
                            </organization>
                            <status>Active</status>
                            <statusDate>01-01-1980 00:00:00</statusDate>
                        </studyOrganization>
                        <studyOrganization role="Document to Participant Organization" updatedDate="01-04-2001 17:16:21"
                                           createdDate="12-29-1998 15:33:36">
                            <localDocumentNumber>SEG-INT-81-306</localDocumentNumber>
                            <organization>
                                <ctepId>SG</ctepId>
                                <organizationName>Southeastern Cancer Study Group</organizationName>
                                <organizationType>ITN</organizationType>
                            </organization>
                            <status>Active</status>
                            <statusDate>01-01-1980 00:00:00</statusDate>
                        </studyOrganization>
                        <studyOrganization role="Document to Participant Organization" updatedDate="01-04-2001 17:16:21"
                                           createdDate="12-29-1998 15:33:36">
                            <localDocumentNumber>SWOG-8093</localDocumentNumber>
                            <organization>
                                <ctepId>SWOG</ctepId>
                                <organizationName>Southwest Oncology Group</organizationName>
                                <organizationType>CGP</organizationType>
                            </organization>
                            <status>Active</status>
                            <statusDate>01-01-1980 00:00:00</statusDate>
                        </studyOrganization>
                        <studyOrganization role="Document to Participant Organization" updatedDate="04-10-2007 14:51:30"
                                           createdDate="12-29-1998 15:33:31">
                            <localDocumentNumber>GRP-81-001</localDocumentNumber>
                            <organization>
                                <ctepId>PMB</ctepId>
                                <organizationName>Pharmaceutical Management Branch</organizationName>
                                <organizationType>NCP</organizationType>
                            </organization>
                            <status>Active</status>
                            <statusDate>01-01-1980 00:00:00</statusDate>
                        </studyOrganization>
                    </studyOrganizations>
                    <studyTherapies>
                        <therapy updatedDate="02-16-2005 17:17:19" createdDate="10-21-1999 11:48:59">
                            <ctepName>Drug and/or Immunotherapy</ctepName>
                            <medDRACode>90003006</medDRACode>
                        </therapy>
                    </studyTherapies>
                    <studyTreatmentAssignments/>
                    <title>Phase III - treatment of advanced malignant mesothelioma: a comparison of
                        cia(cyclophosphamide, dtic, adriamycin) vs ca(cyclophosphamide, adriamycin)
                    </title>
                </StudyDetails>
            </data>
        </operation>
    </response>
</payload>